Before prescribing any treatment, laboratory testing should confirm the presence of a fungal nail infection. Although it is likely that the patient’s symptoms are due to onychomycosis, other conditions such as psoriasis should be ruled out. Oral terbinafine would be a suitable treatment option if the test confirms a fungal infection. However, topical antifungal treatments are generally not ideal for nail infections. A topical corticosteroid is not appropriate for treating a fungal nail infection, but may be considered if the test reveals no fungal involvement and there are signs of an inflammatory dermatosis like psoriasis. While taking a nail sample is necessary, antifungal treatment should not be initiated until the fungal cause is confirmed. This is because different nail conditions can have similar appearances, and starting treatment without confirmation would not be beneficial.

Fungal Nail Infections: Causes, Symptoms, and Treatment

Fungal nail infections, also known as onychomycosis, can affect any part of the nail or the entire nail unit. However, toenails are more susceptible to infection than fingernails. The primary cause of fungal nail infections is dermatophytes, with Trichophyton rubrum being the most common. Yeasts, such as Candida, and non-dermatophyte molds can also cause fungal nail infections. Risk factors for developing a fungal nail infection include increasing age, diabetes mellitus, psoriasis, and repeated nail trauma.

The most common symptom of a fungal nail infection is thickened, rough, and opaque nails. Patients may present with unsightly nails, which can be a source of embarrassment. Differential diagnoses include psoriasis, repeated trauma, lichen planus, and yellow nail syndrome. To confirm a fungal nail infection, nail clippings or scrapings of the affected nail should be examined under a microscope and cultured. However, the false-negative rate for cultures is around 30%, so repeat samples may be necessary if clinical suspicion is high.

Asymptomatic fungal nail infections do not require treatment unless the patient is bothered by the appearance. Topical treatment with amorolfine 5% nail lacquer is recommended for limited involvement, while oral terbinafine is the first-line treatment for more extensive involvement due to a dermatophyte infection. Fingernail infections require 6 weeks to 3 months of therapy, while toenails should be treated for 3 to 6 months. Oral itraconazole is recommended for more extensive involvement due to a Candida infection, with pulsed weekly therapy being the preferred method.

Compression stockings should only be offered to patients with deep vein thrombosis who are experiencing post-thrombotic syndrome (PTS), which typically occurs 6 months to 2 years after the initial DVT and is characterized by chronic pain, swelling, hyperpigmentation, and venous ulcers. Apixaban is not appropriate for treating PTS, as it is used to treat acute DVT. Codeine may help with pain but doesn’t address the underlying cause. Hirudoid cream is not effective for treating PTS, as it is used for superficial thrombophlebitis. If conservative management is not effective, patients may be referred to vascular surgery for surgical treatment. Compression stockings are the first-line treatment for PTS, as they improve blood flow and reduce symptoms in the affected calf.

Post-Thrombotic Syndrome: A Complication of Deep Vein Thrombosis

Post-thrombotic syndrome is a clinical syndrome that may develop following a deep vein thrombosis (DVT). It is caused by venous outflow obstruction and venous insufficiency, which leads to chronic venous hypertension. Patients with post-thrombotic syndrome may experience painful, heavy calves, pruritus, swelling, varicose veins, and venous ulceration.

While compression stockings were previously recommended to reduce the risk of post-thrombotic syndrome in patients with DVT, Clinical Knowledge Summaries now advise against their use for this purpose. However, compression stockings are still recommended as a treatment for post-thrombotic syndrome. Other recommended treatments include keeping the affected leg elevated.

In summary, post-thrombotic syndrome is a potential complication of DVT that can cause a range of uncomfortable symptoms. While compression stockings are no longer recommended for prevention, they remain an important treatment option for those who develop the syndrome.

Prenatal Screening Tests: An Overview

One of the routine tests offered to pregnant women is the second trimester anomaly scan, which screens for fetal abnormalities. However, for more specific testing, amniocentesis and chorionic villus sampling (CVS) are available. Amniocentesis is typically done between weeks 15-20 of pregnancy and can detect Down’s syndrome, spina bifida, and other conditions. CVS, on the other hand, is done between weeks 10-13 and is only offered to those with a high risk of serious inherited conditions. The first trimester scan is mainly used to confirm and date the pregnancy, while the second trimester anomaly scan is used to detect fetal abnormalities. The nuchal translucency (NT) scan is also offered as part of the NHS screening program between weeks 11-13.6 of pregnancy. It’s important to note that while these tests are available, they are not routinely offered to all women and carry a small risk of miscarriage.

Patients taking canagliflozin should be closely monitored for any ulcers or infections on their legs and feet, as there is a potential increased risk of amputation. Canagliflozin is a medication that blocks the reabsorption of glucose in the kidneys, leading to increased urinary glucose excretion. However, this can also increase the risk of urogenital infections and dehydration. Patients should seek medical attention if they notice any skin discoloration or ulcers.

Before starting treatment with canagliflozin, it is important to monitor renal function and continue to do so annually. While there has been some debate about a potential association between dapagliflozin and bladder cancer, canagliflozin has been deemed safe and effective by NICE as a recommended therapy.

Canagliflozin is generally well-tolerated and doesn’t pose any significant swallowing difficulties. However, some patients may experience a metallic taste disturbance when taking metformin, another commonly prescribed medication for diabetes.

Understanding SGLT-2 Inhibitors

SGLT-2 inhibitors are medications that work by blocking the reabsorption of glucose in the kidneys, leading to increased excretion of glucose in the urine. This mechanism of action helps to lower blood sugar levels in patients with type 2 diabetes mellitus. Examples of SGLT-2 inhibitors include canagliflozin, dapagliflozin, and empagliflozin.

However, it is important to note that SGLT-2 inhibitors can also have adverse effects. Patients taking these medications may be at increased risk for urinary and genital infections due to the increased glucose in the urine. Fournier’s gangrene, a rare but serious bacterial infection of the genital area, has also been reported. Additionally, there is a risk of normoglycemic ketoacidosis, a condition where the body produces high levels of ketones even when blood sugar levels are normal. Finally, patients taking SGLT-2 inhibitors may be at increased risk for lower-limb amputations, so it is important to closely monitor the feet.

Despite these potential risks, SGLT-2 inhibitors can also have benefits. Patients taking these medications often experience weight loss, which can be beneficial for those with type 2 diabetes mellitus. Overall, it is important for patients to discuss the potential risks and benefits of SGLT-2 inhibitors with their healthcare provider before starting treatment.

Visual Disturbances: Causes and Management

Visual disturbances can be caused by various conditions, including retinal transient ischaemic attack (TIA), central retinal artery occlusion, retinal vein occlusion, middle cerebral artery infarct, and migraine. Amaurosis fugax, or transient monocular blindness, may precede a central retinal artery occlusion or a stroke. Urgent referral to ophthalmology is necessary within the first 24 hours, and methods such as anterior chamber paracentesis, intravenous Diamox®, ocular massage, and breathing into a paper bag may help restore vision. Retinal vein occlusion causes sudden painless unilateral loss of vision, while middle cerebral artery infarct produces a wide variety of neurological deficits, including visual consequences such as gaze preference towards the side of the lesion and contralateral homonymous hemianopia. Migraine visual aura consists of an area that is not well seen, surrounded by shimmering zig-zag lines, that gradually enlarges and then breaks up over a period of 15-30 minutes. Proper management and investigation are necessary to prevent further complications and ensure appropriate treatment.

Understanding Hypertension Diagnosis and Management

Hypertension is a common condition that requires careful diagnosis and management. According to the 2019 NICE guidance on Hypertension (NG136), ambulatory or home blood pressure should be checked if a patient has a blood pressure equal to or greater than 140/90 mmHg. If the systolic reading is above 140 mmHg, it is considered a sign of hypertension.

The guidelines also state that lifestyle advice should be given to all patients, and drug treatment should be considered if there are signs of end organ damage or if the patient’s CVD risk is greater than 10% in 10 years. For patients under 40 years old, referral to a specialist should be considered.

It is important to note that NICE guidance is not the only source of information on hypertension diagnosis and management. While it is important to have an awareness of the latest guidance, it is also important to have a balanced view and consider other guidelines and consensus opinions.

In summary, understanding the diagnosis and management of hypertension is crucial for general practitioners. The 2019 NICE guidance on Hypertension provides important information on thresholds for diagnosis and management, but it is important to consider other sources of information as well.

Differential Diagnosis for a Unilateral Eye Condition

One possible diagnosis for a patient with a unilateral eye condition is a corneal ulcer, which can be caused by contact lens use and may lead to serious complications if left untreated. However, other conditions should also be considered. Viral conjunctivitis, which is typically bilateral and accompanied by copious discharge, may follow a viral upper respiratory tract infection. Chlamydial conjunctivitis, on the other hand, is not usually unilateral and doesn’t involve fluorescein uptake. A dendritic ulcer, caused by herpes simplex virus, is characterized by small branching epithelial dendrites and doesn’t exhibit central fluorescein uptake. Finally, a foreign body may cause similar symptoms, but would typically be visible upon examination and not involve central fluorescein staining. A thorough differential diagnosis is necessary to accurately diagnose and treat a patient’s eye condition.

Understanding Infant Bowel Movements: Breastfed Babies and Constipation

Breastfed infants tend to have more frequent bowel movements than formula-fed babies, but there is a wide range of normal variation. It is common for breastfed babies to have frequent bowel movements up to six weeks of age due to the gastro-colic reflex. However, it is also normal for breastfed babies to go several days without a bowel movement, sometimes up to 7-10 days. When a bowel movement does occur after a longer period of time, it may be a blow-out of normal consistency and should not cause concern as long as it appears painless.

It is important to note that simple straining to pass stool is also normal and doesn’t necessarily indicate constipation. However, if there are worrying signs such as difficulty with feeding, failure to gain weight, or signs of discomfort, medical attention should be sought.

It is not necessary to give a macrogol laxative unless a diagnosis of constipation is made. Additionally, introducing baby food containing fruit and vegetables is not appropriate for exclusively breastfed infants. Prune juice may help with constipation, but it is not recommended for infants until they are weaned at 4-6 months.

Overall, as long as the baby is well and examination is normal, there is no need for urgent referral to hospital. However, if constipation appears during the first few weeks of life, it may be a sign of a more serious condition such as Hirschsprung’s disease, which requires medical attention.

Stomatitis: Causes and Associated Factors

Stomatitis is a condition that can be caused by ill-fitting dentures and slack facial muscles, which can lead to Candida overgrowth. It is not associated with reactive arthritis, but it may be seen in Behçet’s disease. While it is not directly linked to constipation, it can be associated with inflammatory bowel disease.

Iron deficiency is a possible factor in the development of stomatitis, as are deficiencies in riboflavin, niacin, pyridoxine, folic acid, and cyanocobalamin. Vitamin C deficiency can also cause stomatitis, as well as scurvy.

It is important to address the underlying causes of stomatitis in order to effectively treat the condition. Proper dental care and nutrition can help prevent stomatitis from developing or recurrent.

Drug Interactions with Warfarin

Ciprofloxacin, a cytochrome p450 inhibitor, can prolong the half-life of warfarin and increase the international normalized ratio (INR). However, the reaction is not always predictable, and susceptibility may be influenced by factors such as fever, infection, or malnutrition. While aspirin is known to increase the risk of bleeding due to its antiplatelet activity, it doesn’t have a clear relationship with INR.

Drugs that are metabolized in the liver can induce hepatic microsomal enzymes, which can increase the rate of metabolism of another drug, resulting in lower plasma concentrations and a reduced effect. St. John’s wort is an enzyme inducer and can increase the metabolism of warfarin, making it less effective. It is important to be aware of potential drug interactions with warfarin to ensure its effectiveness and prevent adverse effects.

Fortunately, Helena falls within the 72-hour window period for commencing post-exposure prophylaxis (PEP) for HIV, and as such, she should start PEP without delay.

Post-Exposure Prophylaxis for Viral Infections

Post-exposure prophylaxis (PEP) is a preventive treatment given to individuals who have been exposed to a viral infection. The type of PEP given depends on the virus and the clinical situation. For hepatitis A, either human normal immunoglobulin or the hepatitis A vaccine may be used. For hepatitis B, the PEP given depends on whether the source is known to be positive for HBsAg or not. If the person exposed is a known responder to the HBV vaccine, then a booster dose should be given. If they are a non-responder, they need to have hepatitis B immune globulin and a booster vaccine. For hepatitis C, monthly PCR is recommended, and if seroconversion occurs, interferon +/- ribavirin may be given. For HIV, a combination of oral antiretrovirals should be given as soon as possible for four weeks. The risk of HIV transmission depends on the incident and the current viral load of the patient. For varicella zoster, VZIG is recommended for IgG negative pregnant women or immunosuppressed individuals. The risk of transmission for single needlestick injuries varies depending on the virus, with hepatitis B having a higher risk than hepatitis C and HIV.

Overall, PEP is an important preventive measure for individuals who have been exposed to viral infections. It is crucial to determine the appropriate PEP based on the virus and the clinical situation to ensure the best possible outcome.

Although cervical cancer screening is effective in detecting squamous cell cancer, it may not be as effective in detecting adenocarcinomas. Even with the switch to liquid based cytology, the detection rate for adenocarcinomas has not improved.

Understanding Cervical Cancer Screening in the UK

Cervical cancer screening is a well-established program in the UK that aims to detect Premalignant changes in the cervix. This program is estimated to prevent 1,000-4,000 deaths per year. However, it should be noted that cervical adenocarcinomas, which account for around 15% of cases, are frequently undetected by screening.

The screening program has evolved significantly in recent years. Initially, smears were examined for signs of dyskaryosis, which may indicate cervical intraepithelial neoplasia. However, the introduction of HPV testing allowed for further risk stratification. Patients with mild dyskaryosis who were HPV negative could be treated as having normal results. The NHS has now moved to an HPV first system, where a sample is tested for high-risk strains of human papillomavirus (hrHPV) first, and cytological examination is only performed if this is positive.

All women between the ages of 25-64 years are offered a smear test. Women aged 25-49 years are screened every three years, while those aged 50-64 years are screened every five years. Cervical screening cannot be offered to women over 64, unlike breast screening, where patients can self-refer once past screening age. In Scotland, screening is offered from 25-64 every five years.

In special situations, cervical screening in pregnancy is usually delayed until three months postpartum, unless there has been missed screening or previous abnormal smears. Women who have never been sexually active have a very low risk of developing cervical cancer and may wish to opt-out of screening.

While there is limited evidence to support it, the current advice given out by the NHS is that the best time to take a cervical smear is around mid-cycle. Understanding the cervical cancer screening program in the UK is crucial for women to take control of their health and prevent cervical cancer.

Meniere’s disease is a condition that affects the inner ear and its cause is unknown. It is more commonly seen in middle-aged adults but can occur at any age and affects both men and women equally. The condition is characterized by the excessive pressure and progressive dilation of the endolymphatic system. The main symptoms of Meniere’s disease are recurrent episodes of vertigo, tinnitus, and sensorineural hearing loss. Vertigo is usually the most prominent symptom, but patients may also experience a sensation of aural fullness or pressure, nystagmus, and a positive Romberg test. These episodes can last from minutes to hours and are typically unilateral, but bilateral symptoms may develop over time.

The natural history of Meniere’s disease is that symptoms usually resolve in the majority of patients after 5-10 years. However, most patients will be left with some degree of hearing loss, and psychological distress is common. ENT assessment is required to confirm the diagnosis, and patients should inform the DVLA as the current advice is to cease driving until satisfactory control of symptoms is achieved. Acute attacks can be managed with buccal or intramuscular prochlorperazine, and admission to the hospital may be required. Prevention strategies include the use of betahistine and vestibular rehabilitation exercises, which may be beneficial.

If a child between the ages of 6 and 11 is experiencing an anaphylactic reaction, they should be given a dose of 300 micrograms (0.3ml) of adrenaline. This dose can be repeated every 5 minutes if necessary. Based on the patient’s age of 8 years old, it is recommended to administer the adrenaline at a dose of 300 micrograms IM immediately, as stated in the BNF. It is likely that the child is having an anaphylactic reaction to the nuts they were exposed to in the GP waiting room.

Anaphylaxis is a severe and potentially life-threatening allergic reaction that affects the entire body. It can be caused by various triggers, including food, drugs, and insect venom. The symptoms of anaphylaxis typically develop suddenly and progress rapidly, affecting the airway, breathing, and circulation. Swelling of the throat and tongue, hoarse voice, and stridor are common airway problems, while respiratory wheeze and dyspnea are common breathing problems. Hypotension and tachycardia are common circulation problems. Skin and mucosal changes, such as generalized pruritus and widespread erythematous or urticarial rash, are also present in around 80-90% of patients.

The most important drug in the management of anaphylaxis is intramuscular adrenaline, which should be administered as soon as possible. The recommended doses of adrenaline vary depending on the patient’s age, with the highest dose being 500 micrograms for adults and children over 12 years old. Adrenaline can be repeated every 5 minutes if necessary. If the patient’s respiratory and/or cardiovascular problems persist despite two doses of IM adrenaline, IV fluids should be given for shock, and expert help should be sought for consideration of an IV adrenaline infusion.

Following stabilisation, non-sedating oral antihistamines may be given to patients with persisting skin symptoms. Patients with a new diagnosis of anaphylaxis should be referred to a specialist allergy clinic, and an adrenaline injector should be given as an interim measure before the specialist allergy assessment. Patients should be prescribed two adrenaline auto-injectors, and training should be provided on how to use them. A risk-stratified approach to discharge should be taken, as biphasic reactions can occur in up to 20% of patients. The Resus Council UK recommends a fast-track discharge for patients who have had a good response to a single dose of adrenaline and have been given an adrenaline auto-injector and trained how to use it. Patients who require two doses of IM adrenaline or have had a previous biphasic reaction should be observed for a minimum of 6 hours after symptom resolution, while those who have had a severe reaction requiring more than two doses of IM adrenaline or have severe asthma should be observed for a minimum of 12 hours after symptom resolution. Patients who present late at night or in areas where access to emergency care may be difficult should also be observed for a minimum of 12

Types of Head and Neck Cancer: Symptoms and Characteristics

Squamous cell carcinoma is the most common type of cancer in the upper airway, with the larynx being the most likely location. Symptoms may include pain radiating to the ear, weight loss, and stridor in advanced cases. Small cell carcinoma of the larynx is rare. Adenocarcinoma of the hypopharynx is relatively rare and usually squamous cell carcinoma. Adenocarcinoma and squamous cell carcinoma are common varieties of oesophageal cancer, with dysphagia, anorexia, weight loss, vomiting, and gastrointestinal bleeding being red flag features. Squamous cell carcinoma is the most common type of tonsillar cancer, with symptoms including a sore throat, ear pain, a foreign body sensation, bleeding, and a neck mass. Tonsillar enlargement may be the only sign if the tumour growth is below the surface, or there may be a fungating mass.

Individuals diagnosed with schizophrenia are prohibited from driving and are required to inform the DVLA. They may resume driving with a Group 1 license only after being stable and well for three months, as confirmed by a suitable psychiatric report. The DVLA guidelines specify that patients with schizophrenia can drive if they meet certain criteria, including maintaining stability for at least three months, complying with their treatment plan, regaining insight, being free from medication side effects that could impair driving, and receiving a positive specialist report.

The DVLA has specific rules regarding psychiatric disorders for those who wish to drive group 1 vehicles such as cars and motorcycles. Those with severe anxiety or depression accompanied by memory problems, concentration problems, agitation, behavioral disturbance, or suicidal thoughts must not drive and must inform the DVLA. Those with acute psychotic disorder, hypomania or mania, or schizophrenia must not drive during acute illness and must notify the DVLA. Those with pervasive developmental disorders and ADHD may be able to drive but must inform the DVLA. Those with mild cognitive impairment, dementia, or mild learning disability may be able to drive but must inform the DVLA. Those with severe disability must not drive and must notify the DVLA. Those with personality disorders may be able to drive but must inform the DVLA. The rules for group 2 vehicles such as buses and lorries are stricter.

Treatment for Dyspareunia in postmenopausal Women

This postmenopausal woman is experiencing dyspareunia due to atrophic vaginitis caused by a lack of estrogen. While topical or systemic hormone replacement therapy can be effective treatments, this patient specifically doesn’t want hormonal treatment. In this case, the best option is Sylk moisturizer, one of two non-hormonal preparations available for vaginal atrophy. Replens is the other option.

It’s important to note that KY jelly is a lubricant only and doesn’t come with an applicator. Sylk and Replens are classified as vaginal moisturizers, which can be applied every few days and provide long-lasting relief, including relief of itching. KY jelly, on the other hand, is only effective until the water evaporates, which is typically within an hour.

In summary, for postmenopausal women experiencing dyspareunia due to atrophic vaginitis, non-hormonal vaginal moisturizers like Sylk and Replens can be effective treatments.

Somatisation Disorder: A Likely Diagnosis

Somatisation disorder is a condition characterized by recurrent physical complaints such as pains, gastrointestinal, sexual, and pseudo-neurologic symptoms that persist over a period of years. Although the brief scenario doesn’t provide enough criteria to make a definitive diagnosis, the symptoms described suggest that somatisation disorder is the most likely answer.

To meet the diagnostic criteria for somatisation disorder, the patient’s physical complaints must not be intentionally induced and must result in medical attention or significant impairment in social, occupational, or other important areas of functioning. Typically, the first symptoms appear in adolescence, and the full criteria are met by 30 years of age.

Among the other disorders, factitious disorder is the least likely, while the other three are possible but not as probable as somatisation. Overall, the scenario suggests that somatisation disorder should be considered as a potential diagnosis, and further evaluation is necessary to confirm or rule out this condition.

An urgent referral to an ophthalmologist is necessary within one week for this patient suspected of having age-related macular degeneration (AMD). The patient is experiencing worsening vision, photopsia, and has drusen on fundoscopy, all of which are consistent with AMD. It is important to rule out wet AMD, which can lead to preventable blindness. Referring to an optometrist or prescribing medication such as latanoprost or vitamins is not appropriate at this stage. The patient requires urgent ophthalmological intervention.

Age-related macular degeneration (ARMD) is a common cause of blindness in the UK, characterized by degeneration of the central retina (macula) and the formation of drusen. The risk of ARMD increases with age, smoking, family history, and conditions associated with an increased risk of ischaemic cardiovascular disease. ARMD is classified into dry and wet forms, with the latter carrying the worst prognosis. Clinical features include subacute onset of visual loss, difficulties in dark adaptation, and visual hallucinations. Signs include distortion of line perception, the presence of drusen, and well-demarcated red patches in wet ARMD. Investigations include slit-lamp microscopy, colour fundus photography, fluorescein angiography, indocyanine green angiography, and ocular coherence tomography. Treatment options include a combination of zinc with anti-oxidant vitamins for dry ARMD and anti-VEGF agents for wet ARMD. Laser photocoagulation is also an option, but anti-VEGF therapies are usually preferred.

If a pregnant patient has a penicillin allergy and is diagnosed with cellulitis, the recommended antibiotic is erythromycin as per the NICE antimicrobial guidance. Flucloxacillin and co-amoxiclav should not be prescribed in this case. It is important to note that doxycycline, a tetracycline antibiotic, is contraindicated in pregnancy and should not be prescribed.

Understanding Cellulitis: Symptoms, Diagnosis, and Treatment

Cellulitis is a common skin infection caused by Streptococcus pyogenes or Staphylococcus aureus. It is characterized by inflammation of the skin and subcutaneous tissues, usually on the shins, accompanied by erythema, pain, swelling, and sometimes fever. The diagnosis of cellulitis is based on clinical features, and no further investigations are required in primary care. However, bloods and blood cultures may be requested if the patient is admitted and septicaemia is suspected.

To guide the management of patients with cellulitis, NICE Clinical Knowledge Summaries recommend using the Eron classification. Patients with Eron Class III or Class IV cellulitis, severe or rapidly deteriorating cellulitis, very young or frail patients, immunocompromised patients, patients with significant lymphoedema, or facial or periorbital cellulitis (unless very mild) should be admitted for intravenous antibiotics. Patients with Eron Class II cellulitis may not require admission if the facilities and expertise are available in the community to give intravenous antibiotics and monitor the patient.

The first-line treatment for mild/moderate cellulitis is flucloxacillin, while clarithromycin, erythromycin (in pregnancy), or doxycycline is recommended for patients allergic to penicillin. Patients with severe cellulitis should be offered co-amoxiclav, cefuroxime, clindamycin, or ceftriaxone. Understanding the symptoms, diagnosis, and treatment of cellulitis is crucial for effective management and prevention of complications.

The relative risk (RR) or risk ratio is a measure of the probability of an outcome in an exposed group compared to an unexposed group. It is calculated by dividing the incidence among the exposed by the incidence among the unexposed. To calculate the absolute risk increase, subtract the absolute risk in the control group from the absolute risk in the event group. The number needed to harm is calculated by dividing one by the absolute risk increase and multiplying by 100 if expressed as a percentage. To calculate the absolute risk, divide the number of events in a group by the number of people in the group and multiply by 100. The relative risk increase is calculated by dividing the experimental event rate minus the control event rate by the control event rate and multiplying by 100.

The use of Nexplanon® IMP is not limited by age and is licensed for contraception for a period of 3 years. It contains 68 mg etonogestrel and doesn’t pose an increased risk of VTE, stroke, or MI. Additionally, it has not been found to have a significant impact on bone mineral density (BMD). While the progesterone-only injectable contraceptive may initially decrease BMD, this effect is not exacerbated by menopause.

Implanon and Nexplanon are both subdermal contraceptive implants that slowly release the hormone etonogestrel to prevent ovulation and thicken cervical mucous. Nexplanon is an updated version of Implanon with a redesigned applicator to prevent deep insertions and is radiopaque for easier location. It is highly effective with a failure rate of 0.07/100 women-years and lasts for 3 years. It doesn’t contain estrogen, making it suitable for women with a history of thromboembolism or migraines. It can be inserted immediately after a termination of pregnancy. However, a trained professional is needed for insertion and removal, and additional contraception is required for the first 7 days if not inserted on days 1-5 of the menstrual cycle.

The main disadvantage of these implants is irregular and heavy bleeding, which can be managed with a co-prescription of the combined oral contraceptive pill. Other adverse effects include headache, nausea, and breast pain. Enzyme-inducing drugs may reduce the efficacy of Nexplanon, and women should switch to a different method or use additional contraception until 28 days after stopping the treatment. Contraindications include ischaemic heart disease/stroke, unexplained vaginal bleeding, past breast cancer, severe liver cirrhosis, and liver cancer. Breast cancer is a UKMEC 4 condition, meaning it represents an unacceptable risk if the contraceptive method is used.

The QALY: Measuring Cost Effectiveness of Treatments

The QALY (Quality-Adjusted Life Year) is a tool used to measure the clinical effectiveness of different treatments and compare their cost effectiveness. It takes into account the quality of life factors of a patient, such as pain level, mobility, mood, and ability to carry out daily activities, and assigns equal weight to each factor. The resulting quality of life rating ranges from negative values (worst possible health) to 1 (best possible health).

The QALY can be used to determine how many extra months or years of life a patient might gain from a treatment of reasonable quality. It is also used to calculate the cost effectiveness of a treatment, by dividing the extra cost of the treatment by the additional QALY gained. For example, if a new drug costs £10,000 and provides an additional 0.7 QALY, the cost per QALY gained would be £10,000/0.7 = £14,285.

NICE (National Institute for Health and Care Excellence) considers each drug on a case-by-case basis, but generally considers treatments costing more than £20,000-30,000 per QALY to be not cost effective. The QALY is a valuable tool in determining the most effective and efficient treatments for patients.

According to the NICE guideline for croup management, it is recommended that all patients receive a single dose of oral dexamethasone at a dosage of 0.15mg/kg, regardless of the severity of their condition. In the event that dexamethasone is not available, a one-time dose of oral prednisolone at a dosage of 1-2 mg/kg may be used as an alternative, but it may need to be repeated after 24 hours. Antibiotics are not effective in treating croup as it is caused by a virus.

Croup is a respiratory infection that affects young children, typically those between 6 months and 3 years old. It is most common in the autumn and is caused by parainfluenza viruses. The main symptom is stridor, which is caused by swelling and secretions in the larynx. Other symptoms include a barking cough, fever, and cold-like symptoms. The severity of croup can be graded based on the child’s symptoms, with mild cases having occasional coughing and no audible stridor at rest, and severe cases having frequent coughing, prominent stridor, and significant distress or lethargy. Children with moderate or severe croup should be admitted to the hospital, especially if they are under 6 months old or have other airway abnormalities. Diagnosis is usually made based on clinical symptoms, but a chest x-ray can show subglottic narrowing. Treatment typically involves a single dose of oral dexamethasone or prednisolone, and emergency treatment may include high-flow oxygen or nebulized adrenaline.

Acute Limb Ischaemia: Urgent Treatment Required

Patients experiencing acute limb ischaemia require immediate medical attention to potentially save their limb. This condition is characterized by several features, including pain, pallor, pulselessness, paraesthesia, paralysis, and perishingly cold skin. Pain is always present, and the ankle pulses are always absent. A useful rule of thumb is that if you can count the pulse, it’s there, but if not, it probably isn’t. Paraesthesia and paralysis are late, limb-threatening signs that require urgent treatment. Therefore, patients with acute limb ischaemia should be admitted as an emergency to receive potentially limb-saving treatment.

The cause of the patient’s intracranial hypertension is likely due to the use of prednisolone. If the optic nerve becomes compressed, sudden loss of vision may occur.

Understanding Idiopathic Intracranial Hypertension

Idiopathic intracranial hypertension, also known as pseudotumour cerebri, is a medical condition that is commonly observed in young, overweight females. The condition is characterized by a range of symptoms, including headache, blurred vision, and papilloedema, which is usually present. Other symptoms may include an enlarged blind spot and sixth nerve palsy.

There are several risk factors associated with idiopathic intracranial hypertension, including obesity, female sex, pregnancy, and certain drugs such as the combined oral contraceptive pill, steroids, tetracyclines, vitamin A, and lithium.

Management of idiopathic intracranial hypertension may involve weight loss, diuretics such as acetazolamide, and topiramate, which can also cause weight loss in most patients. Repeated lumbar puncture may also be necessary, and surgery may be required to prevent damage to the optic nerve. This may involve optic nerve sheath decompression and fenestration, or a lumboperitoneal or ventriculoperitoneal shunt to reduce intracranial pressure.

It is important to note that if intracranial hypertension is thought to occur secondary to a known cause, such as medication, it is not considered idiopathic. Understanding the risk factors and symptoms associated with idiopathic intracranial hypertension can help individuals seek appropriate medical attention and management.

When a child presents with rapidly worsening and painful eczema that is not responding to usual treatment, it may be an early sign of eczema herpeticum. This is a medical emergency that requires urgent assessment and treatment with antivirals to prevent systemic complications. Therefore, the most appropriate action is same-day referral to paediatrics. Oral aciclovir, oral flucloxacillin, and topical clobetasol are not the most appropriate actions in this case. Mild cases may respond to oral antivirals, but a thorough assessment is necessary, and IV antiviral treatment may be required for facial involvement. Definitive treatment for eczema herpeticum is antivirals, not antibiotics or topical steroids.

Eczema herpeticum is a serious skin infection caused by herpes simplex virus 1 or 2. It is commonly observed in children who have atopic eczema and is characterized by a rapidly progressing painful rash. The affected area usually shows monomorphic punched-out erosions, which are circular, depressed, and ulcerated lesions with a diameter of 1-3 mm.

Due to its life-threatening potential, children with eczema herpeticum should be admitted for intravenous aciclovir treatment.

The pneumococcal vaccine comes in two types: the pneumococcal conjugate vaccine (PCV) and the pneumococcal polysaccharide vaccine (PPV). The PCV is given to children as part of their routine immunizations at 3 and 12-13 months. On the other hand, the PPV is offered to adults over 65 years old, patients with chronic conditions such as COPD, and those who have had a splenectomy.

The vaccine is recommended for individuals with asplenia or splenic dysfunction, chronic respiratory disease, chronic heart disease, chronic kidney disease, chronic liver disease, diabetes mellitus, immunosuppression, cochlear implants, and patients with cerebrospinal fluid leaks. However, controlled hypertension is not an indication for vaccination. Patients with any stage of HIV infection are also included in the list of those who should be vaccinated.

Adults usually require only one dose of the vaccine, but those with asplenia, splenic dysfunction, or chronic kidney disease need a booster every five years. It is important to note that asthma is only included if it requires the use of oral steroids at a dose sufficient to act as a significant immunosuppressant.

When using Ellaone, it is recommended to wait for 5 days before starting the combined contraceptive pill and to use barrier contraception for 7 days. This is because taking progestogen within 5 days of using Ulipristal may reduce its effectiveness as an emergency contraceptive. Waiting for this period and avoiding further unprotected sexual intercourse ensures that Ellaone is as effective as possible in preventing pregnancy. When starting the combined contraceptive pill, patch, or ring, or the progesterone-only implant or injection, barrier contraception should be used for 7 days. For Qlaira contraceptive pill, barrier contraceptives should be used for 9 days, and for the progesterone-only pill, for 2 days after starting the method.

Emergency contraception is available in the UK through two methods: emergency hormonal contraception and intrauterine device (IUD). Emergency hormonal contraception includes two types of pills: levonorgestrel and ulipristal. Levonorgestrel works by stopping ovulation and inhibiting implantation, and should be taken as soon as possible after unprotected sexual intercourse (UPSI) for maximum efficacy. The single dose of levonorgestrel is 1.5mg, but should be doubled for those with a BMI over 26 or weight over 70kg. It is safe and well-tolerated, but may cause vomiting in around 1% of women. Ulipristal, on the other hand, is a selective progesterone receptor modulator that inhibits ovulation. It should be taken within 120 hours after intercourse, and may reduce the effectiveness of hormonal contraception. The most effective method of emergency contraception is the copper IUD, which may inhibit fertilization or implantation. It must be inserted within 5 days of UPSI, or up to 5 days after the likely ovulation date. Prophylactic antibiotics may be given if the patient is at high-risk of sexually transmitted infection. The IUD is 99% effective regardless of where it is used in the cycle, and may be left in-situ for long-term contraception.

This young female patient is likely suffering from Graves’ disease, causing hyperthyroidism and symptoms such as sweating, palpitations, and restlessness. A low TSH and high T4 confirm the diagnosis, along with positive TRAbs. While waiting for secondary care, starting carbimazole is the appropriate course of action to alleviate symptoms. Seeking senior or remote specialist advice can help with prescribing. Referring to the emergency department is unnecessary as the palpitations are occasional and the ECG shows sinus tachycardia. Starting amiodarone is not recommended as it can cause thyroid dysfunction and the ECG shows sinus tachycardia, not atrial fibrillation. Continuing to wait for secondary care review doesn’t address the patient’s symptoms and concerns.

Management of Graves’ Disease

Despite numerous trials, there is no clear consensus on the optimal management of Graves’ disease. Treatment options include anti-thyroid drugs (ATDs), radioiodine treatment, and surgery. In recent years, ATDs have become the most popular first-line therapy for Graves’ disease. This is particularly true for patients with significant symptoms of thyrotoxicosis or those at risk of hyperthyroid complications, such as elderly patients or those with cardiovascular disease.

To control symptoms, propranolol is often used to block the adrenergic effects. NICE Clinical Knowledge Summaries recommend that patients with Graves’ disease be referred to secondary care for ongoing treatment. If symptoms are not controlled with propranolol, carbimazole should be considered in primary care.

ATD therapy involves starting carbimazole at 40 mg and gradually reducing it to maintain euthyroidism. This treatment is typically continued for 12-18 months. The major complication of carbimazole therapy is agranulocytosis. An alternative regime, called block-and-replace, involves starting carbimazole at 40 mg and adding thyroxine when the patient is euthyroid. This treatment typically lasts for 6-9 months. Patients following an ATD titration regime have been shown to suffer fewer side-effects than those on a block-and-replace regime.

Radioiodine treatment is often used in patients who relapse following ATD therapy or are resistant to primary ATD treatment. Contraindications include pregnancy (should be avoided for 4-6 months following treatment) and age < 16 years. Thyroid eye disease is a relative contraindication, as it may worsen the condition. The proportion of patients who become hypothyroid depends on the dose given, but as a rule, the majority of patients will require thyroxine supplementation after 5 years.